Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
liquid phase concentrated growth factor
- Development stage
- Phase 2
- Lead developer
- Silfradent
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intraarticular, Injection, Topical
01
Overview
Liquid phase concentrated growth factor (LPCGF) is a third-generation autologous platelet concentrate derived from the patient's own blood through a specialized centrifugation process. Unlike traditional concentrated growth factor (CGF), which typically forms a gel or fibrin clot, LPCGF maintains a liquid state for a period, allowing it to be used as an injectable therapeutic or mixed with grafting materials such as deproteinized bovine bone minerals (DBBM). It contains high concentrations of growth factors including vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGF-β), and platelet-derived growth factor (PDGF), along with CD34-positive hematopoietic stem cells and leukocytes. These components promote neovascularization, tissue regeneration, and anti-inflammatory responses. LPCGF is primarily utilized in regenerative dentistry, oral and maxillofacial surgery (particularly for temporomandibular joint disorders), and aesthetic plastic surgery for improving fat graft survival.
- Other names
- liquid CGFliquid concentrated growth factorliquid phase CGF
Beyond the preview
Go deeper on liquid phase concentrated growth factor.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on liquid phase concentrated growth factor.